Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 100 of 161 publications.

Register TC, Jayo MJ, Anthony MS. Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys. J Clin Endocrinol Metab. 2003 Sep;88(9):4362-70.

Gilsenan A, Pedrazzani S, Bennett L, Li L, Yeager W, Haas JC. Observational prevalence study of HSV-2 (Genital Herpes) in suburban primary-care practices: data collection procedures and sampling methods. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 21, 2003.

McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CE, van Assche D. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol. 2003 Aug 1;149(2):323-31.

Gimeno V, Castellsague J, Varas-Lorenzo C, Hopkins JS, Eaton SC, Perez-Gutthann S. Gastrointestinal and cardiovascular characterization of users of COX-2 specific inhibitors. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1):43.

Earnshaw SR, Wirth K, Hicks KA. Pilot test of the RTI HIV prevention resource allocation tool. Presented at the Florida Department of Health; August 2003.

Garcia-Rodriguez LA, Varas-Lorenzo C, Maguire A, Castellsague J, Gonzalez-Perez A, Perez-Gutthann S, Arellano A. Non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and the risk of acute myocardial infarction in the UK. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1):117.

Harris DH. Stage of diagnosis among medically underserved women in California. Presented at the National Breast and Cervical Cancer Early Detection Program Conference; August 2003.

Arana A, Castellsague J, Trave F, Perez-Gutthann S, Rothman KJ, Arellano FM. Early estimation of excess risk of serious cutaneous reactions for newly marketed drugs. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1):165.

Granger AL, Fehnel SE, Bell T. Humanistic and financial impacts of restless legs syndrome form the patients' perspective. Poster presented at the 7th Congress of the European Federation of Neurological Societies; August 2003.

Njue AI, Prichard RK. Heterologous expression of glutamate-gated chloride channel subunits from cooperia oncophora. Poster presented at the 19th International Conference of the World Association for the Advancement of Veterinary Parasitology; August 2003.

Varas-Lorenzo C, Maguire A, Perez-Gutthann S. Serum potassium levels, hypertension and antihypertensive treatment in the US adult population: NHANES III (1988-1994). Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1):54.

Chromy J, Odom DM, Eyerman J, McNeeley M, Hughes A. The effect of interviewer experience on the interview process in the national survey on drug use and health. Poster presented at the Proceedings of the American Statistical Association, Section on Survey Research Methods; August 2003. San Francisco, CA.

Carnethon MR, Anthony MS, Cascio WE, Folsom AR, Rautaharju PM, Liao D, Evans GW, Heiss G. A prospective evaluation of the risk of QT prolongation with hormone replacement therapy: the atherosclerosis risk in communities study. Ann Epidemiol. 2003 Aug;13(7):530-6.

Rivero E, Huerta C, Garcia-Rodriguez LA, Fernandez-Vidaurre C, Abrams BB. The risk of lymphoid neoplasms and other hematological malignancies in patients with atopic dermatitis. Poster presented at the 19th International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(Suppl 1):S110-1.

Cain VS, Johannes CB, Avis NE, Mohr B, Schocken M, Skurnick J, Ory M. Sexual functioning and practices in a multi-ethnic study of midlife women: baseline results from SWAN. J Sex Res. 2003 Aug 1;40(3):266-76.

Hicks KA, Honeycutt AA, Earnshaw SR, Richter A. A tool for comparing allocations of HIV prevention resources. Presented at the National HIV Prevention Conference; August 2003.

Langagergaard V, Norgard B, Mellemkjaer L, Pendersen L, Rothman KJ, Sorensen HT. Seasonal variation in month of birth and diagnosis in children and adolescents with Hodgkin's disease and non-Hodgkin's lymphoma. J Pediatr Hematol Oncol. 2003 Jul;25(7):534-8.

Vine MF, Calingaert B, Berchuck A, Schildkraut JM. Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol. 2003 Jul 1;90(1):75-82.

Hagell P, Whalley D, McKenna SP, Lindvall 0. Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile. Mov Disord. 2003 Jul 1;18(7):773-83.

Galant SP, Melamed IR, Nayak AS, Blake KV, Prillaman BA, Reed KD, Cook CK, Philpot EE, Rickard KA. Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients. Pediatrics. 2003 Jul;112(1 Pt 1):96-100. doi: 10.1542/peds.112.1.96

Hicks KA. Using computer simulation modeling for process evaluation. Presented at the National Environmental Monitoring Conference; July 2003.

Anthony MS. Foods, herbs and dietary supplements: role in disease prevention. Presented at the Sara Lee Health Education Series; June 17, 2003. Winston-Salem, NC.

Zarkin GA, Dunlap LJ, Hicks KA, Mamo D, Mobley LR. Benefits and costs of methadone treatment: results from a lifetime simulation model. Presented at the International Health Economics Association Meeting; June 15, 2003.

Britt DM, Kubin M, Keininger D, Trudeau E, Sagnier P, Fugl-Meyer A. Development and validation of the treatment satisfaction scale (TSS) for erectile dysfunction. Poster presented at the 2nd International Consultation on Erectile and Sexual Dysfunctions; June 2003.

Finkelstein EA, Kosa KM. Use of incentives to motivate healthy behaviors among employees. Gender issues. 2003 Jun;21(3):50-9. doi: 10.1007/s12147-003-0005-0

Poulos C, Cahn D, Whittington D, Thoa L, Utomo N, Hoa N. Household demand for typhoid fever vaccines in Hue City, Vietnam: implications for immunization programs. Poster presented at the 4th World Congress of the International Health Economics Association; June 2003.

LoRusso PM, Herbst RS, Rischin D, Ranson M, Calvert H, Raymond E, Kieback D, Kaye S, Gianni L, Harris A, Bjork T, Maddox A, Rothenberg ML, Small EJ, Rubin EH, Feyereislova A, Heyes A, Averbuch SD, Ochs J, Baselga J. Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors. Clin Cancer Res. 2003 Jun 1;9(6):2040-8.

Hallfors D, Halpern CT, Bauer DJ, Iritani B, Waller MW, Hussey JM, Cho H, Guo G, Vanderpuije A. Examining sex and drug patterns for hiv prevention. Poster presented at the Annual Meeting of the Society for Prevention Research; June 2003.

Harris DH, Bates J. Evaluating the effectiveness of breast cancer screening programs in California. Poster presented at the North American Association of Central Cancer Registries Annual Conference; June 2003.

Carnethon MR, Anthony MS, Cascio WE, Folsom AR, Rautaharju PM, Liao D, Evans GW, Heiss G. Prospective association between hormone replacement therapy, heart rate, and heart rate variability. The Atherosclerosis risk in communities study. J Clin Epidemiol. 2003 Jun;56(6):565-71.

Sapienza S, Sacco P, Floyd K, DiCesare J, Doan Q. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting. Clin Ther. 2003 Jun;25(6):1872-87.

Britt D, Kubin M, Keininger D, Trudeau E, Sagnier P, Fugl-Meyer A. Development and validation of the treatment satisfaction scale (TSS) for erectile dysfunction. Pharmacotherapy. 2003 Jun;23(10):132.

Hicks KA. A study of the response times of state public health labs in a chemical terrorism incident using a computer simulation model. Poster presented at the Public Health Labs Chemical Terrorism Workshop; June 2003.

Coombs JH, Abetz L, Keininger DL, Earle CC, Copley-Merriman K, Hsu M-A, Bury-Maynard DP. Development of the Cancer Chemotherapy Satisfaction Questionnaire (CCSQ): part I: item-generation and content validity testing. Poster presented at the 39th Annual Meeting of the American Society of Clinical Oncology; May 2003. Chicago, IL. [abstract] American Society Of Clinical Oncology Meeting Proceedings. 2003 May; 22:545.

Fehnel SE, McLeod LD, Williams VS. Combining qualitative and quantitative techniques in the development of patient-reported outcome measures. Presented at the Eighth Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research; May 2003.

Osoba D, Hsu M-A, Copley-Merriman K, Johnson FR, Hauber AB, Coombs J. Cancer patients' preferences for health-related quality of life (HRQOL) domains during treatment. Poster presented at the 2003 Annual Meeting of the American Society of Clinical Oncology; May 2003.

Rothman KJ, Funch DP, Alfredson T, Brady J, Dreyer NA. Randomized field trial of vaginal douching, pelvic inflammatory disease, and pregnancy. Epidemiology. 2003 May;14(3):340-8.

Stavisky RC, Watson SL, Anthony MS, Manuck SB, Adams MR, Kaplan JR. Influence of estradiol on cortisol secretion in ovariectomized cynomolgus macaques (Macaca fascicularis). Am J Primatol. 2003 May;60(1):17-22.

Earnshaw SR, Richter A, Hicks KA, Honeycutt A. The allocation of HIV prevention funds. Poster presented at the 2003 ISPOR 8th Annual International Meeting; May 2003.

Cella D, Natale R, Lynch T T, Lee C, Carbone D, Douillard JY, Kay A, Wolf M, Heyes AE, Ward J. Disease-related symptoms in advanced nsclc as measured by the lung cancer subscale (LCS) of the fact-l questionnaire: clinically meaningful improvement with gefitinib (Iressa, ZD1839). Presented at the American Society of Clinical Oncology; May 2003. Chicago, IL.

Santanello NC, DeMuro-Mercon CJ, Philip G, Schenkel E, Shah SR. Impact of seasonal allergic rhinitis on sleep: importance rating study. Poster presented at the American Thoracic Society; May 2003.

Santanello NC, DeMuro-Mercon CJ, Philip G, Ratner PH. Differences in functioning and well-being based on sleep quality in allergic rhinitis. Poster presented at the European Academy of Allergology and Clinical Immunology; May 2003.

Ackerman SJ, Mordin M, Reblando J, Xu X, Schein J, Vallow S, Brennan M. Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain. J Manag Care Pharm. 2003 May 1;9(3):223-31.

Suparto IH, Williams JK, Cline JM, Anthony MS, Fox JL. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys. Am J Obstet Gynecol. 2003 May;188(5):1132-40.

Rivero E, Alexander M, Iribarren C, Ordoñez J, Shandling M, Go AS. Lipid monitoring and lipid profiles in kidney transplant patients within a large health maintenance organization: 1995-1999. Poster presented at the American Transplant Congress; May 2003. Washington, DC.

Baldus T, Nehra A, Brock G, Britt DM. Influence of vardenafil, a potent, highly selective phosphodiesterase-5 inhibitor on improving erectile function and depressive symptomatology in patients with erectile dysfunction secondary to radical nerve-sparing prostatectomy. Poster presented at the 31st Annual Meeting of the American Academy of Physician Assistants; May 2003.

Clark M, Copley-Merriman K, Coombs JH, Von Pawel J, Koschel G, Pauer LR. Patient reported outcomes (symptoms, functioning, and quality of life [QOL]) in a randomized Phase II study of CI-994 plus carboplatin and paclitaxel (C/T) vs placebo (PBO) plus C/T in the first-line treatment of patients with advanced nonsmall cell lung cancer (NSCLC). Poster presented at the 39th Annual Meeting of the American Society of Clinical Oncology; May 2003. Chicago, IL. [abstract] American Society Of Clinical Oncology Meeting Proceedings. 2003 May; 22:687.

Manga N, Duffy JC, Rowe PH, Cronin MTD. A hierarchical QSAR model for urinary excretion of drugs in humans as a predictive tool for biotransformation. QSAR Comb Sci. 2003 Apr 17;22(2):263-73. doi: 10.1002/qsar.200390021

Michels KB, Rothman KJ. Update on unethical use of placebos in randomised trials. Bioethics. 2003 Apr;17(2):188-204.

Iida M, Anna CH, Hartis J, Bruno M, Wetmore B, Dubin JR, Sieber S, Bennett L, Cunningham ML, Paules RS, Tomer KB, Houle CD, Merrick AB, Sills RC, Devereux TR. Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. Carcinogenesis. 2003 Apr 1;24(4):757-70.